Neural therapy
Defines coverage stance for neural therapy (injection of local anesthetic into scars, trigger points, acupuncture points, peripheral nerves, autonomic ganglia, epidural space, and other tissues) for commercial and Medicare Advantage products; notes benefits may vary by contract and refers to benefit booklet for member-specific coverage.
No material clinical/coverage changes
Coverage Summary & Determination
Neural therapy involves injection of a local anesthetic (e.g., procaine or lidocaine) into tissues such as scars, trigger points, acupuncture points, tendon and ligament insertions, peripheral nerves, autonomic ganglia, the epidural space, and other tissues to treat chronic pain and other proposed conditions. The policy's overall stance is that neural therapy is not covered / considered not medically necessary for all indications because the evidence is insufficient to determine effects on health outcomes.